USPTO trademark

TAVOCEPT

AllowedUSPTOWord markClass 5

"TAVOCEPT" is a word mark owned by Lantern Pharma Inc., filed at the USPTO on July 19, 2022. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
TAVOCEPT trademark as filed
As filed with the USPTO
Status
Allowed
Since July 10, 2026
Filed
July 19, 2022
Registered
Not yet
Expires
Not recorded
Application no.
97510148
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns TAVOCEPT

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services TAVOCEPT is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, medications used in chemotherapeutic regimens for the treatment of cancer; pharmaceutical preparations for the treatment of cancer

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 4 granted
  3. Sou extension 4 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 3 granted
  7. Sou extension 3 filed
  8. Sou teas extension received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 2 granted

10 earlier steps on the official record.

FAQ

About TAVOCEPT

Who owns the trademark "TAVOCEPT"?

The USPTO trademark "TAVOCEPT" (application 97510148) is owned by Lantern Pharma Inc.

What is the status of "TAVOCEPT"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TAVOCEPT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2ac6-6a13-77eb-a431-c33a4e2782ef
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ac6-6a13-77eb-a431-c33a4e2782ef",
  "object": "trademark",
  "mark_text": "TAVOCEPT",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "97510148",
  "filing_date": "2022-07-19",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Lantern Pharma Inc.",
      "entity_id": "ent_019eb717-849f-7289-98eb-8fb06e0056c2"
    }
  ]
}